Scientists develop artificial chemical receptor to assist viral transduction for T cell engineering
Monday, April 15, 2019 - 08:50
in Biology & Nature
Engineered T cell immunotherapy, such as chimeric antigen receptor T cell (CAR-T) and T cell receptor T cell (TCR-T) therapy, has emerged as a potent therapeutic strategy for treating tumors.